ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas

Press/Media

Period	7 May 2025

Media coverage

Title	ECM Therapeutics Receives FDA IDE Approval for U.S. Feasibility Study of ECMT-100 in Treatment of Anorectal Fistulas
Media name/outlet	BioSpace
Country/Territory	United States
Date	7/05/25
URL	https://www.biospace.com/press-releases/ecm-therapeutics-receives-fda-ide-approval-for-u-s-feasibility-study-of-ecmt-100-in-treatment-of-anorectal-fistulas
Persons	Stephen Badylak